View in EDS

Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma.

Saved in:
Bibliographic Details
Title: Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma.
Authors: Wen CY; Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan., Tsui KH; Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.; Institute of Biopharmaceutical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan., Chang CH; Department of Traditional Chinese Medicine, Tainan Municipal Hospital, Tainan 701, Taiwan., Chiu YH; Department of Microbiology, Soochow University, Taipei 111, Taiwan., Lin SA; Department of Nursing, National Yang Ming Chiao Tung University Hospital, Taipei 112, Taiwan.; Nursing School of National Yang Ming Chiao Tung University, Yilan 260, Taiwan., Chu CY; Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan., Li CJ; Department of Obstetrics and Gynecology, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.; Institute of Biopharmaceutical Sciences, National Sun Yat-Sen University, Kaohsiung 804, Taiwan.
Source: Journal of oncology [J Oncol] 2022 Jan 29; Vol. 2022, pp. 9854788. Date of Electronic Publication: 2022 Jan 29 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Hindawi Publishing Corporation Country of Publication: Egypt NLM ID: 101496537 Publication Model: eCollection Cited Medium: Print ISSN: 1687-8450 (Print) Linking ISSN: 16878450 NLM ISO Abbreviation: J Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1687-8450
DOI:10.1155/2022/9854788